Popular Aussie pawpaw ointment urgently recalled over contamination fears

People who may have recently purchased a Lucas’ pawpaw ointment product are being urged to immediately check it after several batches were recalled.

Australia’s medicine regulator, the Therapeutic Goods Administration (TGA), has issued an urgent recall of 11 batches of the topical ointments, due to fears they may contain microbiological contamination.

The microorganisms some batches are contaminated with have are Aspergillus tubingensis, Sordaria humana, Penicillium paneum and Paenibacillus glucanolyticus.


The impacted batch numbers are 00522D22, 00522E04, 00522E05, 00822E25, 00822E26, 00822E27, 00822E30, 00822E31, 00822F01, 00822F03, 00822F06, which expire between April and June 2025.


The TGA said that while these moulds and bacteria pose “minimal risk” to the general population, there is a “remote risk” that individuals who are immunocompromised could become ill if they are exposed.

“In-line sampling to monitor the microbial content of batches in production returned out of specification (OOS) results greater than limits set by the sponsor,” The TGA recall states.

“Quality hold was placed on the products at distribution level, and the samples were retested at another validated laboratory for microbiology testing to allow for further confirmation of OOS results.

“Both validated microbiology laboratories for the sponsor have returned OOS results across bulk batches 00822 and 00522.

“Wholesalers and distributors are advised to identify and immediately quarantine affected stock from Bulk Batches 00522 and 00822, advise if it has been distributed, and arrange for destruction or return of stock.

“Consumers are advised to return product to the place of purchase for a refund.”